✦ LIBER ✦

Lack of benefit at 5 years from a short course of neoadjuvant/concurrent androgen deprivation for unfavorable prostate cancer patients treated to a high total radiation dose

✍ Scribed by A Martinez; R Galalae; C Mitchell; G Gustafson; G Edmundson; G Kovacs

Book ID: 108435265
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 95 KB
Volume: 57
Category: Article
ISSN: 0360-3016
DOI: 10.1016/s0360-3016(03)00962-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

No Apparent Benefit at 5 Years From a Co

No Apparent Benefit at 5 Years From a Course of Neoadjuvant/Concurrent Androgen Deprivation for Patients With Prostate Cancer Treated With a High Total Radiation Dose

✍ MARTINEZ, ALVARO; GALALAE, RAZVAN; GONZALEZ, JOSE; MITCHELL, CHRISTINA; GUSTAFSO 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 109 KB

882 Is a short course of neoadjuvant/con

882 Is a short course of neoadjuvant/concurrent androgen deprivation beneficial for prostate cancer patients treated with a locally dose escalated radiation protocol?

✍ A. Martinez; R. Galalae; C. Mitchell; N. Nuemberg; G. Gustafson; G. Edmundson; G 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Continued Benefit to Androgen Deprivatio

Continued Benefit to Androgen Deprivation Therapy for Prostate Cancer Patients Treated With Dose-Escalated Radiation Therapy Across Multiple Definitions of High-Risk Disease

✍ Matthew H. Stenmark; Kevin Blas; Schuyler Halverson; Howard M. Sandler; Felix Y. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 475 KB